Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.

Wave Life Sciences Pte. Ltd ( (WVE) ) has released its Q3 earnings. Here is a breakdown of the information Wave Life Sciences Pte. Ltd ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Avidity Biosciences stock surges on expansion of pipeline targeting rare genetic cardiomyopathies and improvements in siRNA ...

Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...

Our best-in-class RNA platform is consistently translating in the clinic and demonstrating how we can uniquely design, and ...

CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical-stage immunology company ...

Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

The company describes the precision medicine test as the first of its kind to offer simultaneous whole exome sequencing and ...

Avidity Biosciences ( (RNA) ) has provided an announcement. Avidity Biosciences is making strides in precision cardiology with its development ...

SLN ("Silence" or the "Company"), a global clinical stage biotechnology company committed to transforming people’s lives by ...